Two AI peer review tools with different strengths and publication workflows.
Fukurō and ARBITER both analyze complete research manuscripts before submission.
ARBITER focuses strongly on methodology, statistics, scientific rigor, clinical relevance, and reference integrity. Its public documentation states that it is strongest in clinical and biomedical research.
Fukurō evaluates the research contribution, methodology, experimental design, results, argumentation, structure, citations, limitations, and conclusions. Its Complete plan adds figure and visual evaluation, journal guideline compliance, rebuttal response analysis, and manuscript version comparison.
The main difference is what each platform emphasizes and how far it supports the manuscript after the initial review.
Bottom line
Choose Fukurō if you want a detailed manuscript review and tools that remain useful after submission. In addition to reviewing the research itself, Fukurō Complete can evaluate figures, check journal requirements, analyze responses to reviewers, and compare the original and revised manuscripts.
ARBITER may be a better fit if your main priority is a one time review with strong attention to methodology, statistics, clinical relevance, and reference integrity, particularly for biomedical research.
Both platforms provide substantive manuscript review. The clearer difference appears in their specialization and the workflows available after the first assessment.
Feature comparison
| Capability | Fukurō | ARBITER |
|---|---|---|
| Full manuscript review | ✓ | ✓ |
| Research contribution | ✓ | Not listed as a separate review dimension |
| Methodology and study design | ✓ | ✓ |
| Experimental design | ✓ | ✓ |
| Results and supporting evidence | ✓ | ✓ |
| Statistical analysis | SAMPL statistical reporting checks | Statistical appropriateness |
| Argumentation and conclusions | ✓ | Unsupported conclusions checked |
| Citation analysis | ✓ | ✓ Dedicated verification |
| Retraction checking | No dedicated workflow | ✓ |
| Figure and visual evaluation | Complete | No dedicated workflow publicly listed |
| Journal guideline compliance | Complete | No journal specific audit publicly listed |
| Rebuttal response analysis | Complete | No dedicated workflow publicly listed |
| Manuscript version comparison | Complete | No dedicated workflow publicly listed |
| Interactive review discussion | ✓ | No dedicated workflow publicly listed |
| Biomedical specialization | Not discipline specific | Strongest in clinical and biomedical research |
| PDF and DOCX support | ✓ | ✓ |
| Subscription option | ✓ | — |
| Individual review purchase | — | ✓ |
Complete = available with Fukurō Complete. “No dedicated workflow publicly listed” means that ARBITER's current public documentation does not describe a separate feature for that task. It does not mean that its general review cannot identify a related issue.
Last reviewed: September 2026. Product features and pricing may change.
Fukurō evaluates more than isolated technical issues
Fukurō is not primarily a grammar, formatting, or structure checker.
Its peer review examines:
- research contribution;
- methodology;
- experimental design;
- results;
- argumentation;
- structure;
- citations;
- limitations;
- conclusions.
Grammar and writing checks support this analysis but are not its main purpose.
The review can identify relationships between issues in different parts of the manuscript. For example, a methodological limitation may weaken a central conclusion, a result may not fully support the stated contribution, or the Introduction and Conclusion may describe the contribution differently.
Each finding includes an explanation and severity level so the author can distinguish major concerns from smaller improvements.
ARBITER has a clear biomedical focus
ARBITER is developed by AI-HEART Lab and was designed by a practicing cardiologist and physician scientist.
Its public documentation emphasizes:
- study design;
- methodology;
- statistical appropriateness;
- scientific rigor;
- clinical significance;
- unsupported conclusions;
- reference integrity.
ARBITER states that it is strongest in clinical and biomedical research, although it can review other scientific manuscripts that contain a Methods section.
This makes its positioning particularly clear for clinical studies and other biomedical research.
Fukurō is not positioned around one research discipline. Its review criteria are intended for academic manuscripts across research areas.
ARBITER provides dedicated reference verification
Reference checking is one of ARBITER's clearest specialized features.
Its citation integrity process checks references against:
- CrossRef;
- PubMed;
- OpenAlex;
- Retraction Watch.
The system checks whether references can be found, flags suspected fabricated references, identifies retracted papers, and evaluates whether cited sources support the associated claims.
Fukurō evaluates citations as part of the manuscript review, including citation gaps and weak support that may affect the research argument.
However, Fukurō does not currently provide the same dedicated external reference verification process.
If reference integrity is your main concern, ARBITER provides the more specialized capability.
Statistical review
The platforms describe their statistical checks differently.
Fukurō Standard includes statistical reporting checks using SAMPL. These checks focus on how statistical methods and results are reported in the manuscript.
ARBITER evaluates statistical appropriateness as part of its scientific review.
These are not identical capabilities.
Fukurō does not claim that its SAMPL checks independently validate every statistical decision in a study. ARBITER places statistical appropriateness more centrally in its review, particularly for biomedical research.
What happens after the first review?
This is where the difference between the platforms becomes more important.
ARBITER is primarily designed for manuscript review before submission.
Fukurō supports additional stages of the publication process:
Manuscript → Review → Revision → Submission → Reviewer comments → Rebuttal analysis → Revised manuscript → Version comparison
These stages involve different questions, so Fukurō provides separate workflows for them.
Rebuttal response analysis
Fukurō Complete analyzes reviewer comments together with the author's proposed responses.
It can identify:
- reviewer concerns that remain unanswered;
- responses that address only part of a comment;
- weak or unclear justifications;
- tone problems;
- manuscript changes mentioned in the response but not yet addressed.
The purpose is specific:
Does the response address what the reviewer requested?
ARBITER does not currently list a dedicated rebuttal analysis workflow.
Manuscript version comparison
Fukurō Complete compares the original manuscript with the revised version.
It can identify:
- additions;
- deletions;
- structural changes;
- citation differences;
- whether requested revisions appear in the new manuscript.
This helps authors verify that revisions described in the response letter are actually present in the revised paper.
ARBITER does not currently list manuscript version comparison as a dedicated feature.
Figure and visual evaluation
Fukurō Complete includes figure and visual evaluation as part of the manuscript review.
This allows visual material to be assessed together with the text.
AI-HEART Lab offers a separate product called CANVAS for creating scientific illustrations and graphical abstracts, but ARBITER's public documentation does not describe a dedicated workflow for evaluating figures already present in a manuscript.
Creating figures and reviewing existing figures are different tasks.
Journal preparation
The platforms approach journal preparation differently.
ARBITER states that its review criteria are calibrated to the expectations of high impact biomedical journals.
Fukurō Complete includes a journal guideline compliance audit for researchers who have already selected a target journal.
The distinction is straightforward:
ARBITER applies review criteria informed by biomedical journal expectations.
Fukurō checks the manuscript against the requirements of the selected journal.
These are related but different functions.
Privacy and manuscript retention
ARBITER states that manuscripts are not used for AI training, that Zero Data Retention is enabled across its AI infrastructure, and that manuscript files are deleted after the review is delivered.
Fukurō states that manuscripts are not used to train its own models. Uploaded files and extracted manuscript text are temporarily retained for processing and are automatically deleted from active systems within three days after the review or rebuttal is created.
If immediate deletion after review delivery is an important requirement, ARBITER has the shorter stated retention period.
Pricing
The products use different pricing models.
Fukurō
Standard
$24/month
$240/year
- 25 credits per month
- Full multi-agent manuscript review
- Statistical reporting checks using SAMPL
- Grammar and writing checks
- Severity rated findings with PDF report
- Email support
Complete
$49/month
$490/year
Everything in Standard, plus:
- Figure and visual evaluation
- Journal guideline compliance audit
- Rebuttal response analysis
- Manuscript version comparison
- Priority support
ARBITER
First credit
Free
AI-HEART Lab states that the first credit for each product is free
Review credits
Credits do not expire
- 1 review
- $29.99
- 3 reviews
- $74.99
- 5 reviews
- $109.99
Fukurō's Standard and Complete plans provide the same monthly credit allowance. Complete adds additional review and revision workflows.
Enterprise pricing is available separately for ARBITER.
The pricing models suit different usage patterns.
ARBITER may be more convenient for researchers who want occasional individual reviews without a subscription.
Fukurō is designed for researchers who expect to use manuscript review together with additional submission and revision workflows.
Which one fits your workflow?
Choose Fukurō if you want
- evaluation of the research contribution;
- methodology and experimental design analysis;
- assessment of results and argumentation;
- citation and limitation checks;
- evaluation of conclusions;
- severity rated findings;
- statistical reporting checks;
- figure and visual evaluation;
- journal guideline compliance;
- rebuttal response analysis;
- manuscript version comparison;
- support after receiving reviewer comments.
ARBITER may fit better if you want
- individual reviews without a subscription;
- a review focused on clinical or biomedical research;
- strong attention to methodology and statistical appropriateness;
- clinical relevance checks;
- dedicated reference verification;
- checks for fabricated or retracted references;
- manuscript deletion after the review is delivered.
Frequently asked questions
Is ARBITER a real peer review product?
Yes.
ARBITER is an active manuscript review product from AI-HEART Lab. It evaluates scientific manuscripts before journal submission and focuses on methodology, statistics, scientific rigor, and reference integrity.
Is ARBITER only for biomedical research?
No.
ARBITER states that it can review scientific manuscripts outside medicine when they contain a Methods section.
However, its own documentation says that it is strongest in clinical and biomedical research.
Is Fukurō only a grammar or structure checker?
No.
Fukurō evaluates the research contribution, methodology, experimental design, results, argumentation, structure, citations, limitations, and conclusions.
Grammar and writing checks support the manuscript review rather than define it.
Which platform provides stronger reference verification?
ARBITER currently provides the more specialized reference verification workflow.
Its citation integrity system checks references against CrossRef, PubMed, OpenAlex, and Retraction Watch.
Fukurō evaluates citations as part of its manuscript review but does not currently provide the same external reference verification process.
Which platform is more useful after receiving reviewer comments?
Fukurō provides dedicated tools for this stage.
Fukurō Complete includes rebuttal response analysis and manuscript version comparison.
ARBITER's current public product information focuses on manuscript review before submission and does not describe equivalent workflows.
Which platform is more suitable outside biomedical research?
ARBITER can review research outside medicine, but it explicitly states that it is strongest in clinical and biomedical research.
Fukurō is not positioned around a specific discipline and is designed for academic manuscripts across research areas.
Does ARBITER evaluate figures?
ARBITER's current public documentation does not describe a dedicated figure evaluation workflow.
AI-HEART Lab offers CANVAS as a separate tool for creating scientific illustrations and graphical abstracts.
Fukurō Complete includes figure and visual evaluation of the manuscript itself.
Which platform provides better peer review?
There is not enough directly comparable public evidence to claim that one platform always provides better peer review.
A meaningful quality comparison would require running the same manuscripts through both systems and evaluating the resulting reports using the same criteria.
The clearer difference is specialization. ARBITER focuses strongly on biomedical review and reference integrity. Fukurō combines manuscript assessment with tools for journal compliance, reviewer responses, and manuscript revision.
Continue beyond the first review
Fukurō supports more than the initial manuscript assessment.
Review the manuscript. Address reviewer comments. Verify the revision.